Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids

Eitemau Tebyg

• Lack of Pharmacokinetic Interaction between the Oral Anti-Influenza Prodrug Oseltamivir and Aspirin
  gan: Oo, Charles, et al.
  Cyhoeddwyd: (2002)
• Lack of effect of moderate hepatic impairment on the pharmacokinetics of oral oseltamivir and its metabolite oseltamivir carboxylate
  gan: Snell, Paul, et al.
  Cyhoeddwyd: (2005)
• Increasing Oral Absorption of Polar Neuraminidase Inhibitors: A Prodrug Transporter Approach Applied to Oseltamivir Analogue
  gan: Gupta, Deepak, et al.
  Cyhoeddwyd: (2013)
• Anti-Influenza Neuraminidase Inhibitor Oseltamivir Phosphate Induces Canine Mammary Cancer Cell Aggressiveness
  gan: de Oliveira, Joana T., et al.
  Cyhoeddwyd: (2015)
• Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071
  gan: Li, Weixing, et al.
  Cyhoeddwyd: (1998)